EMA
approval
· 2025-06-24
EMA Authorised: Tolucombi (telmisartan;hydrochlorothiazide) — Krka, d.d., Novo mesto
Summary
The European Medicines Agency has authorized Tolucombi, a fixed-dose combination tablet of telmisartan and hydrochlorothiazide, for the treatment of hypertensio…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Status: Authorised. Therapeutic area: Hypertension. MAH: Krka, d.d., Novo mesto. Decision date: 19/06/2025